FDA
twiist: How It Works, Features, Latest Updates
The twiist automated insulin delivery system is based on Tidepool Loop, a user-friendly algorithm that grew out of the open-source diabetes community. Approved for people with type 1 diabetes ages 6 and up, twiist automates dosing, allows users to set a glucose target as low as 87 mg/dL, and offers meal presets to better deal with different food types.
Zepbound (Tirzepatide) for Chronic Weight Management: Uses, Side Effects, and Cost
Aiming to address demand for its weight loss drug Zepbound (tirzepatide), Eli Lilly is selling the starting dose of the medicine in four single-use vials – or one four-dose pen – to self-pay customers for $299.
FDA Warns Against Compounded Semaglutide for Diabetes, Weight Loss
The FDA has recently issued warnings to companies offering compounded medications with false or misleading claims that their medications are FDA-approved and equivalent in safety to approved drugs like Ozempic.
Vertex Continues Multiple Paths To Potential Islet Cell Cure
After ending the VX-264 trial, which used a device to protect lab-grown islet cells, the company will continue research on therapies with and without the need for immunosuppressive drugs.
How To Make Sure You Receive Critical Blood Sugar Alerts
Like wearing a seatbelt or keeping a fire extinguisher in the kitchen, having a safety system for CGM alerts on your smartphone can be a lifesaver.
